The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Cannabis and schizophrenia. A longitudinal study of Swedish conscripts
Abstract
The association between level of cannabis consumption and development of schizophrenia during a 15-year follow-up was studied in a cohort of 45,570 Swedish conscripts. The relative risk for schizophrenia among high consumers of cannabis (use on more than fifty occasions) was 6.0 (95% confidence interval 4.0-8.9) compared with non-users. Persistence of the association after allowance for other psychiatric illness and social background indicated that cannabis is an independent risk factor for schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Swedish Conscript Study found a dose-response relationship between cannabis use by age 18 and incident schizophrenia by age 45 (11,12), with a 3-fold increase in risk in those who reported using cannabis more than 50 times by age 18 (95% CI 1.7, 5.5).”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [11]
In the citing paper
“The Swedish Conscript Study found a dose-response relationship between cannabis use by age 18 and incident schizophrenia by age 45 (11,12), with a 3-fold increase in risk in those who reported using cannabis more than 50 times by age 18 (95% CI 1.7, 5.5).”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [11]
Citations
Cites
Vulnerability: A new view of schizophrenia.
Zubin, J., & Spring, B. (1977) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.86.2.103 · Cited by 1,992
(1985) · Cited by 487
Ohlsson, A., Lindgren, J.-E., Wahlen, A., Agurell, S., Hollister, L. E., & Gillespie, H. K. (1980) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1980.181 · Cited by 475
Theoretical Epidemiology: Principles of Occurrence Research in Medicine
Greenland, S. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380070135039 · Cited by 468
Psychotic Reactions Following Cannabis Use in East Indians
Chopra, G. S. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760070014002 · Cited by 193
CANNABIS-ASSOCIATED PSYCHOSIS WITH HYPOMANIC FEATURES
ROTTANBURG, D. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91270-3 · Cited by 178
Hallucinogenic drugs as precipitants of schizophrenia
Breakey, W. R., Goodell, H., Lorenz, P. C., & McHugh, P. R. (1974) · Psychological Medicine · doi:10.1017/s0033291700042938 · Cited by 143
Cannabis and neuroleptic agents in schizophrenia
Knudsen, P., & Vilmar, T. (1984) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1984.tb02482.x · Cited by 140
Marijuana use in schizophrenia: a clear hazard
Treffert, D. A. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.10.1213 · Cited by 139
Schizophrenia as a brain disease
Henn, F. A., & Nasrallah, H. A. (1982) · Oxford University Press eBooks · Cited by 116
Research works printed but not linked: 1
- Nahas, 1984, Pharmacologic and epidemiological aspects of alcohol and cannabis, NY St J Med, 84, 599
Cited by
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
The environment and schizophrenia
van Os, J., Kenis, G., & Rutten, B. P. F. (2010) · Nature · doi:10.1038/nature09563 · Cited by 1,572
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399
Adverse health effects of non-medical cannabis use
Hall, W., & Degenhardt, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61037-0 · Cited by 1,134
Metadata
- Authors
- Andréasson, S., Engström, A., Allebeck, P., & Rydberg, U.
- Affiliations
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- ORCID
- Andréasson, Sven
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1987-12
- Volume
- 330
- Issue
- 8574
- Pages
- 1483-1486
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2079847735
- Cited by
- 1,166
- References
- 28
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 13 · 2023: 22 · 2022: 36 · 2021: 38 · 2020: 73 · 2019: 50 · 2018: 41 · 2017: 49 · 2016: 76 · 2015: 66 · 2014: 43 · 2013: 34 · 2012: 37
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Psychopathy, Forensic Psychiatry, Sexual Offending
- Keywords
- cannabis use, schizophrenia, risk factors, longitudinal cohort, conscripts, relative risk, mental illness, social background
- MeSH terms
- Adult, Analysis of Variance, Marijuana Abuse, Humans, Longitudinal Studies, Male, Military Personnel, Probability, Surveys and Questionnaires, Risk Factors, Schizophrenia, Sweden
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. https://app.cochat.ai/papers/10.1016/s0140-6736(87)92620-1
- The paper
- Andréasson, S., Engström, A., Allebeck, P., & Rydberg, U. (1987). Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. The Lancet. https://doi.org/10.1016/s0140-6736(87)92620-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.